APT Medical Inc Capital Reinvestment Ratio

Latest as of December 2025: 0.18x

APT Medical Inc capital reinvestment ratio. APT Medical Inc (688617) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.68 Million) in capital expenditures (CN¥52.10 Million). Check APT Medical Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.18x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥294.68 Million
CNY

Capital Expenditures

CN¥52.10 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of APT Medical Inc (2017–2025)

Capital reinvestment ratio of APT Medical Inc from 2017 to 2025. This chart tracks APT Medical Inc's Capital Reinvestment Ratio across 9 annual periods. Also explore 688617 net asset momentum to track the company's year-over-year net asset growth rate.

APT Medical Inc Capital Reinvestment Ratio by Year (2017–2025)

APT Medical Inc capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see 688617 cash flow metrics.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.29x CN¥975.30 Million CN¥285.59 Million ▼ -66.5%
2024 0.87x CN¥743.39 Million CN¥650.24 Million ▲ +198.3%
2023 0.29x CN¥689.06 Million CN¥202.03 Million ▼ -24.8%
2022 0.39x CN¥367.46 Million CN¥143.21 Million ▼ -57.8%
2021 0.92x CN¥181.39 Million CN¥167.38 Million ▲ +209.5%
2020 0.30x CN¥148.24 Million CN¥44.20 Million ▼ -75.8%
2019 1.23x CN¥54.90 Million CN¥67.56 Million ▼ -28.8%
2018 1.73x CN¥18.63 Million CN¥32.20 Million ▼ -11.7%
2017 1.96x CN¥12.91 Million CN¥25.26 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow